Omalizumab, a novel anti-IgE therapy in allergic disorders

By Babu K Suresh   Holgate Stephen T   Arshad S Hasan  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 1049-1058

Informa Healthcare

Access to resources Recommend Favorite

Therapy of allergic bronchial asthma with omalizumab – an anti-IgE monoclonal antibody

By D’Amato Gennaro  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 371-376

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE in allergic asthma and rhinitis: an update

By Morjaria Jaymin B   Gnanakumaran Gnanasekaran   Babu Kesavan Suresh  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1739-1747

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab: a future innovation for treatment of severe ocular allergy?

By Williams Patricia B   Sheppard Jr John D  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1603-1609

Informa Healthcare

Access to resources Recommend Favorite

Relationship between surfactant protein A polymorphisms and allergic rhinitis in a Chinese Han population

By Deng Yuqin   Chen Shiming   Chen Jinhui   Tao Zezhang   Kong Yonggang   Xu Yu   Xiao Bokui   He Qing  

Molecular Biology Reports, Vol. 38, Iss. 3, 2011-03 ,pp. : 1475-1482

Springer Publishing Company

Access to resources Recommend Favorite